HSTM

Healthstream Inc Information Technology Services-Computer Programming, Data Processing, Etc. Russell 3000
$33.70Close $996.8MMarket cap $19.79 – $35.1652-week range Nov 2, 2026Next report · after the close

Highlights

Strengths

  • In a stage-2 uptrend all 8 trend conditions pass
  • Leading the market RS 89 · stronger than 89% of stocks over 12 months
  • Near its high 4% below its 52-week high
  • Earnings growing EPS +29% year on year

Cautions

  • Results soon Nov 2, 2026, in 1 day

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 6, 2026
Off 12-month high 4%
1wk down 4.2% price change
1mo up 13.4% price change
12-month return up 38% market up 11% · its own up 27%
F-score — — Not assessed
Altman Z″ 3.21 Low risk
P/E 54.3× price / earnings
PEG — P/E / EPS growth
P/B 2.8× price / book
Earnings yield up 2.1% EBIT / enterprise value
Cheaper than 56% of the market · around average
Revenue growth up 4% year on year
EPS growth up 29% latest quarter · -13 pts
Sales growth up 13% latest quarter · +2 pts
ROE up 5% return on equity
Free cash margin up 20% $59.6M FCF
D/E 0.00 long-term debt / equity
Net debt / EBITDA -0.6× net cash
Interest cover —EBIT / interest

Trade setup

ATR% 2.6% $0.88 a day · 2×ATR $31.95
RS 89 / 99 vs the universe
Trend 8 / 8 trend template
Relative volume 0.8× vs 50-day average
Up/down volume 1.43 50 sessions
Implied move — no option chain · report Nov 2, 2026
Trend template · 8 of 8

Screen verdict

1 of 3 screens
  • Stage 2 Leader in mixed conditions
    • RS 89
    • Trend 8/8
    • Off 12-month high 4%
    • EPS growth +29% (accel -13 pts)
    • Sales growth +13% (accel +2 pts)
    • Altman Z″ 3.21 (low risk)

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 3, 2026
Results reaction Aug 3, 2026+3% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $304.1M +4% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $244.8M FY2021 · $256.7M FY2022 · $266.8M FY2023 · $279.1M FY2024 · $291.6M FY2025 · $304.1M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $18.3M -8% on FY2024
$0 $25M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $14.1M FY2021 · $5.8M FY2022 · $12.1M FY2023 · $15.2M FY2024 · $20.0M FY2025 · $18.3M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $59.6M +6% on FY2024
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $33.9M FY2021 · $39.0M FY2022 · $49.4M FY2023 · $61.8M FY2024 · $56.3M FY2025 · $59.6M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 6%
  • Free cash 20%
0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 6% · Free cash 14% FY2021 · Net 2% · Free cash 15% FY2022 · Net 5% · Free cash 19% FY2023 · Net 5% · Free cash 22% FY2024 · Net 7% · Free cash 19% FY2025 · Net 6% · Free cash 20%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $36.2M net cash
  • Cash
  • Long-term debt
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $36.6M · Long-term debt $0 FY2021 · Cash $46.9M · Long-term debt $0 FY2022 · Cash $46.0M · Long-term debt $0 FY2023 · Cash $40.3M · Long-term debt $0 FY2024 · Cash $59.5M · Long-term debt $0 FY2025 · Cash $36.2M · Long-term debt $0
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 29.58m -6.1% since FY2020
31.50m 29.58m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 31.50m FY2021 · 31.33m FY2022 · 30.58m FY2023 · 30.30m FY2024 · 30.43m FY2025 · 29.58m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $244.8M $256.7M $266.8M $279.1M $291.6M $304.1M
Operating income $15.8M $8.1M $12.4M $16.0M $21.3M $20.2M
Net income $14.1M $5.8M $12.1M $15.2M $20.0M $18.3M
Net margin 6% 2% 5% 5% 7% 6%
Earnings per share $0.44 $0.18 $0.39 $0.50 $0.66 $0.61
Free cash flow $33.9M $39.0M $49.4M $61.8M $56.3M $59.6M
Free cash margin 14% 15% 19% 22% 19% 20%
Cash $36.6M $46.9M $46.0M $40.3M $59.5M $36.2M
Long-term debt $0 $0 $0 $0 $0 $0
Shareholders' equity $334.1M $339.0M $334.1M $340.8M $359.4M $354.0M
Shares outstanding 31.50m 31.33m 30.58m 30.30m 30.43m 29.58m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 6, 2026 Quarterly ↗ Jun 30, 2026 37d
May 6, 2026 Quarterly ↗ Mar 31, 2026 36d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 7, 2025 Quarterly ↗ Jun 30, 2025 38d
May 9, 2025 Quarterly ↗ Mar 31, 2025 39d
Feb 28, 2025 Annual ↗ Dec 31, 2024 59d
Oct 24, 2024 Quarterly ↗ Sep 30, 2024 24d
Jul 25, 2024 Quarterly ↗ Jun 30, 2024 25d
Apr 25, 2024 Quarterly ↗ Mar 31, 2024 25d
Feb 26, 2024 Annual ↗ Dec 31, 2023 57d
Oct 26, 2023 Quarterly ↗ Sep 30, 2023 26d

Current reports